02:23:49 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Aurora Cannabis Inc
Symbol ACB
Shares Issued 998,596,023
Close 2019-03-05 C$ 10.80
Market Cap C$ 10,784,837,048
Recent Sedar Documents

Globe says Cowen commences coverage on Cronos, Aurora

2019-03-06 07:49 ET - In the News

See In the News (C-CRON) Cronos Group Inc

The Globe and Mail reports in its Wednesday, March 6, edition that Cowen & Co. analyst Vivien Azer commenced coverage of a pair of Canadian cannabis companies on Tuesday, Aurora Cannabis ($10.80) and Cronos Group ($31.77). The Globe's David Leeder writes in the Eye On Equities column that Ms. Azer believes Aurora Cannabis is positioned well to benefit from the early days of the country's adult use market. Ms. Azer gave Aurora Cannabis an "outperform" rating, emphasizing its impressive 20-per-cent market share to date. Her share target for Aurora Cannabis is $14, exceeding the average on the Street of $12.69. Liking Cronos Group's story "as an asset-light, global low-cost producer," Ms. Azer began coverage with a "market perform" rating and $29 share target. Analysts on average target the shares at $19.36. The Globe reported on Feb. 13 that Canaccord Genuity analyst Matt Bottomley rated Aurora Cannabis "speculative buy," with a $13 share target. The shares were then worth $9.47. The Globe reported on Dec. 11, 2018, that Mr. Bottomley was maintaining his "hold" rating for Cronos Group. In the item, Mr. Bottomley hiked his share target to $17 from $9. The shares could then be had for $17.09.

© 2024 Canjex Publishing Ltd. All rights reserved.